Key SupportThe WHO’s green light bestows global legitimacy on a Chinese shot that has battled concerns about its efficacy after divergent data was reported from trial sites.
It could provide assurance for developing countries that lack their own regulatory bodies and rely on the organization’s advice on which shots are safe to use.